Nouvelles de la Bourse

Dernières actualités financières · Mis à jour Mai 23, 2026

FTC PBM
▬ mixed

CVS Health (CVS) sous les projecteurs des analystes après le règlement proposé par la FTC lié à la tarification de l'insuline

CVS Health (CVS) Under Analyst Spotlight Following Proposed FTC Settlement Related to Insuling Pricing

The panelists agree that the FTC settlement reduces regulatory uncertainty for CVS's PBM business, but they are divided on whether …

Yahoo Finance · Avr 01, 2026
▬ mixed

JPMorgan Chase (JPM) est confrontée à un contexte difficile entraînant des retraits importants dans l'ensemble du secteur

JPMorgan Chase (JPM) Faces Challenging Backdrop Driving Large Withdrawals Across Industry

Despite industry-wide redemption spikes and concerns over lending standards and software/tech exposure, JPM's new private credit fund with redemption gates …

Yahoo Finance · Avr 01, 2026
CMCSA
▬ mixed

BofA réitère Comcast (CMCSA) comme « Acheter » malgré une performance à court terme faible.

BofA Reiterates Comcast (CMCSA) As “Buy” Despite Weak Short-Term Performance

The panel's discussion on Comcast (CMCSA) is mixed, with concerns about structural connectivity decline and high programming costs, but also …

Yahoo Finance · Avr 01, 2026
MU
▬ mixed

Forte sentiment des analystes concernant Micron Technology (MU) à la suite de résultats meilleurs que prévu pour le T2 2026.

Strong Analyst Sentiment on Micron Technology (MU) Following Better-Than-Expected Fiscal Q2 2026 Results

While Micron's Q2 2026 results were impressive, with revenue nearly tripling YoY, the panelists have differing views on its sustainability …

Yahoo Finance · Avr 01, 2026
▬ mixed

Cette action sous-évaluée d'infrastructure d'intelligence artificielle (IA) a grimpé de 80 % en un an. Elle peut encore grimper de 53 %.

This Underrated Artificial Intelligence (AI) Infrastructure Stock Has Surged 80% in a Year. It Can Still Surge 53%.

Jabil's (JBL) strong AI-driven growth and high margins are being challenged by potential margin compression due to hyperscaler leverage and …

Nasdaq · Avr 01, 2026
▬ mixed

La société The Walt Disney Company (DIS) fait face à un revers majeur à son potentiel partenariat majeur avec OpenAI

The Walt Disney Company (DIS) Faces Sebtack to Its Potential Major Partnership with OpenAI

The panelists generally agree that Disney's leadership underperformance, particularly in the streaming sector, is more concerning than the cancellation of …

Yahoo Finance · Avr 01, 2026
▬ mixed

Wegovy de Novo Nordisk approuvé pour la réduction du risque d'événements cardiovasculaires en Angleterre

Novo Nordisk's Wegovy Approved For Cardiovascular Event Risk Reduction In England

NICE's expanded recommendation for Wegovy to reduce future MI/stroke events supports a 'cardio-indication' narrative, potentially increasing NHS addressable demand and …

Nasdaq · Avr 01, 2026
UPST
▼ bear…

Ce titre de fintech tourne-t-il enfin à la rentabilité ?

Is This Fintech Stock Finally Turning the Corner on Profitability?

The panel consensus is bearish on Upstart, with key concerns being margin compression, cyclicality, and reliance on a few large …

Nasdaq · Avr 01, 2026
▬ mixed

ETF du mercredi avec volume inhabituel : DBEU

Wednesday's ETF with Unusual Volume: DBEU

The panel discusses unusual volume in DBEU ETF, with Nebius Group's spike and STMicroelectronics' activity drawing attention. The key debate …

Nasdaq · Avr 01, 2026
▬ mixed

Rapport quotidien sur les dividendes : GNL,WSO,MUR,LW,RPM

Daily Dividend Report: GNL,WSO,MUR,LW,RPM

The panel had mixed views on the recent dividend announcements, with some seeing them as a sign of confidence while …

Nasdaq · Avr 01, 2026
▬ mixed

Le Royaume-Uni est le pays européen le plus vulnérable aux pénuries de kérosène, selon le patron de Ryanair

UK is most vulnerable European country to jet fuel shortages, Ryanair boss says

The panel agrees that Ryanair faces significant short-term risks due to UK-specific jet fuel exposure, with potential capacity cuts in …

The Guardian · Avr 01, 2026
▬ mixed

Eli Lilly obtient l'approbation tant attendue de la FDA pour sa pilule contre l'obésité. Voici ce qu'il faut savoir

Eli Lilly secures long-awaited FDA approval for its obesity pill. Here's what to know

The panel is divided on Eli Lilly's Foundayo approval, with concerns about payer pushback, geopolitical risks, and competitive dynamics, but …

CNBC · Avr 01, 2026